References
Recht A, et al. Postmastectomy radiotherapy: an American society of clinical oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update. Pract Radiat Oncol. 2016;6(6):e219–e234.
Giuliano AE, et al. Effect of axillary dissection vs. no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–926.
Galimberti V, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305.
Jagsi R, et al. Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol. 2014;32(32):3600.
Mamtani A, et al. Axillary micrometastases and isolated tumor cells are not an indication for post-mastectomy radiotherapy in stage 1 and 2 breast cancer. Ann Surg Oncol. 2017;24(8):2182–2188.
FitzSullivan E. et al. Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy. Ann Surg Oncol. 2017;24(3):652–659.
Wu SP, et al. Post-mastectomy radiation therapy in breast cancer patients with nodal micrometastases. Ann Surg Oncol. 2018;25(9):2620–26231.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The author has no conflicts of interest to disclose.
Additional information
ASO Author Reflections is a brief invited commentary on the article, “Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases”, Ann Surg Oncol. 2018;25:2620–2631.
Rights and permissions
About this article
Cite this article
Gerber, N.K., Wu, S.P. ASO Author Reflections: The Role of Post-mastectomy Radiation Therapy in the Setting of Nodal Micrometastases. Ann Surg Oncol 25 (Suppl 3), 659–660 (2018). https://doi.org/10.1245/s10434-018-6922-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6922-7